Barclays’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $184M | Sell |
1,774,398
-986,885
| -36% | -$88.1M | 0.04% | 323 |
|
|
2026
Q1 | $198M | Buy |
2,761,283
+31,056
| +1% | +$2.39M | 0.05% | 295 |
|
|
2025
Q4 | $217M | Sell |
2,730,227
-1,648,988
| -38% | -$130M | 0.05% | 268 |
|
|
2025
Q3 | $330M | Buy |
4,379,215
+856,376
| +24% | +$58.7M | 0.07% | 202 |
|
|
2025
Q2 | $243M | Buy |
3,522,839
+253,050
| +8% | +$16.6M | 0.06% | 231 |
|
|
2025
Q1 | $222M | Sell |
3,269,789
-150,735
| -4% | -$9.02M | 0.06% | 227 |
|
|
2024
Q4 | $154M | Sell |
3,420,524
-2,045,257
| -37% | -$115M | 0.04% | 283 |
|
|
2024
Q3 | $344M | Sell |
5,465,781
-365,464
| -6% | -$21.3M | 0.09% | 157 |
|
|
2024
Q2 | $344M | Buy |
5,831,245
+2,020,523
| +53% | +$126M | 0.11% | 145 |
|
|
2024
Q1 | $304M | Sell |
3,810,722
-480,701
| -11% | -$36.7M | 0.11% | 162 |
|
|
2023
Q4 | $339M | Sell |
4,291,423
-1,612,447
| -27% | -$115M | 0.12% | 132 |
|
|
2023
Q3 | $412M | Buy |
5,903,870
+420,716
| +8% | +$29.8M | 0.26% | 72 |
|
|
2023
Q2 | $379M | Buy |
5,483,154
+2,711,102
| +98% | +$193M | 0.24% | 81 |
|
|
2023
Q1 | $206M | Sell |
2,772,052
-831,946
| -23% | -$69.8M | 0.09% | 137 |
|
|
2022
Q4 | $336M | Buy |
3,603,998
+763,870
| +27% | +$73.7M | 0.15% | 102 |
|
|
2022
Q3 | $271M | Buy |
2,840,128
+573,065
| +25% | +$56.7M | 0.3% | 68 |
|
|
2022
Q2 | $210M | Sell |
2,267,063
-680,507
| -23% | -$66.4M | 0.13% | 113 |
|
|
2022
Q1 | $298M | Sell |
2,947,570
-1,841,150
| -38% | -$193M | 0.23% | 95 |
|
|
2021
Q4 | $494M | Buy |
4,788,720
+874,727
| +22% | +$80.8M | 0.18% | 98 |
|
|
2021
Q3 | $332M | Buy |
3,913,993
+935,143
| +31% | +$78.3M | 0.15% | 103 |
|
|
2021
Q2 | $249M | Buy |
2,978,850
+396,743
| +15% | +$32.5M | 0.12% | 136 |
|
|
2021
Q1 | $194M | Buy |
2,582,107
+237,911
| +10% | +$17.3M | 0.1% | 156 |
|
|
2020
Q4 | $160M | Buy |
2,344,196
+31,461
| +1% | +$2.05M | 0.08% | 174 |
|
|
2020
Q3 | $135M | Sell |
2,312,735
-752,986
| -25% | -$46.9M | 0.08% | 176 |
|
|
2020
Q2 | $199M | Sell |
3,065,721
-880,734
| -22% | -$55.5M | 0.15% | 98 |
|
|
2020
Q1 | $234M | Buy |
3,946,455
+135,264
| +4% | +$9.03M | 0.19% | 78 |
|
|
2019
Q4 | $283M | Buy |
3,811,191
+235,371
| +7% | +$16.5M | 0.16% | 107 |
|
|
2019
Q3 | $226M | Sell |
3,575,820
-840,194
| -19% | -$49.8M | 0.14% | 114 |
|
|
2019
Q2 | $241M | Buy |
4,416,014
+245,209
| +6% | +$13.2M | 0.15% | 105 |
|
|
2019
Q1 | $225M | Sell |
4,170,805
-994,916
| -19% | -$61.4M | 0.16% | 96 |
|
|
2018
Q4 | $338M | Buy |
5,165,721
+2,749,259
| +114% | +$205M | 0.26% | 57 |
|
|
2018
Q3 | $190M | Sell |
2,416,462
-331,295
| -12% | -$23.7M | 0.13% | 108 |
|
|
2018
Q2 | $177M | Sell |
2,747,757
-181,496
| -6% | -$12M | 0.15% | 97 |
|
|
2018
Q1 | $182M | Buy |
2,929,253
+632,874
| +28% | +$45.4M | 0.14% | 118 |
|
|
2017
Q4 | $166M | Buy |
2,296,379
+190,134
| +9% | +$13.8M | 0.14% | 127 |
|
|
2017
Q3 | $171M | Buy |
2,106,245
+158,776
| +8% | +$12.6M | 0.18% | 92 |
|
|
2017
Q2 | $157M | Sell |
1,947,469
-4,758,650
| -71% | -$376M | 0.17% | 87 |
|
|
2017
Q1 | $526M | Buy |
6,706,119
+4,257,294
| +174% | +$340M | 0.57% | 23 |
|
|
2016
Q4 | $193M | Buy |
2,448,825
+1,482,191
| +153% | +$120M | 0.21% | 67 |
|
|
2016
Q3 | $86M | Sell |
966,634
-226,547
| -19% | -$21.4M | 0.1% | 159 |
|
|
2016
Q2 | $114M | Buy |
1,193,181
+299,712
| +34% | +$29.9M | 0.15% | 110 |
|
|
2016
Q1 | $92M | Sell |
893,469
-999,524
| -53% | -$97.2M | 0.14% | 122 |
|
|
2015
Q4 | $184M | Buy |
1,892,993
+814,905
| +76% | +$79.8M | 0.22% | 72 |
|
|
2015
Q3 | $103M | Sell |
1,078,088
-390,273
| -27% | -$41M | 0.12% | 131 |
|
|
2015
Q2 | $153M | Buy |
1,468,361
+39,499
| +3% | +$4.04M | 0.17% | 89 |
|
|
2015
Q1 | $147M | Sell |
1,428,862
-29,242
| -2% | -$2.96M | 0.17% | 97 |
|
|
2014
Q4 | $140M | Buy |
1,458,104
+372,541
| +34% | +$32.8M | 0.13% | 114 |
|
|
2014
Q3 | $85.8M | Buy |
1,085,563
+249,617
| +30% | +$19.7M | 0.08% | 188 |
|
|
2014
Q2 | $62.7M | Sell |
835,946
-453,304
| -35% | -$34.3M | 0.07% | 246 |
|
|
2014
Q1 | $95.4M | Sell |
1,289,250
-369,668
| -22% | -$26.1M | 0.11% | 158 |
|
|
2013
Q4 | $118M | Buy |
1,658,918
+219,215
| +15% | +$14.1M | 0.12% | 130 |
|
|
2013
Q3 | $80.6M | Buy |
1,439,703
+293,402
| +26% | +$17.5M | 0.1% | 175 |
|
|
2013
Q2 | $65.5M | Buy |
+1,146,301
| New | +$66.4M | 0.08% | 192 |
|
Other funds holding CVS
Barclays's CVS Position: Q2 2026 in Review
Barclays reduced its CVS Health (CVS) stake by 36% in Q2 2026, selling an estimated $88.1M and leaving 1,774,398 shares worth $184M. The position accounts for 0.04% of the portfolio, ranked #323.
Barclays first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $526M in Q1 2017. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Barclays held 1,774,398 shares of CVS Health worth $184M as of Q2 2026.
- Barclays sold 986,885 CVS Health shares in Q2 2026, an estimated $88.1M.
- CVS Health made up 0.04% of Barclays's portfolio in Q2 2026, its #323 holding.
- Barclays first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Barclays's CVS Health position peaked at $526M in Q1 2017.
- 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.